Advanced search
Start date
Betweenand


Autophagy deficiency abolishes liver mitochondrial DNA segregation

Full text
Author(s):
Show less -
Tostes, Katiane ; dos Santos, Angelica C. ; Alves, Lindomar O. ; Bechara, Luiz R. G. ; Marascalchi, Rachel ; Macabelli, Carolina H. ; Grejo, Mateus P. ; Festuccia, William T. ; Gottlieb, Roberta A. ; Ferreira, Julio C. B. ; Chiaratti, Marcos R.
Total Authors: 11
Document type: Journal article
Source: AUTOPHAGY; v. 18, n. 10, p. 12-pg., 2022-02-27.
Abstract

Mutations in the mitochondrial genome (mtDNA) are ubiquitous in humans and can lead to a broad spectrum of disorders. However, due to the presence of multiple mtDNA molecules in the cell, co-existence of mutant and wild-type mtDNAs (termed heteroplasmy) can mask disease phenotype unless a threshold of mutant molecules is reached. Importantly, the mutant mtDNA level can change across lifespan as mtDNA segregates in an allele- and cell-specific fashion, potentially leading to disease. Segregation of mtDNA is mainly evident in hepatic cells, resulting in an age-dependent increase of mtDNA variants, including non-synonymous potentially deleterious mutations. Here we modeled mtDNA segregation using a well-established heteroplasmic mouse line with mtDNA of NZB/BINJ and C57BL/6N origin on a C57BL/6N nuclear background. This mouse line showed a pronounced age-dependent NZB mtDNA accumulation in the liver, thus leading to enhanced respiration capacity per mtDNA molecule. Remarkably, liver-specific atg7 (autophagy related 7) knockout abolished NZB mtDNA accumulat ion, resulting in close-to-neutral mtDNA segregation through development into adulthood. prkn (parkin RBR E3 ubiquitin protein ligase) knockout also partially prevented NZB mtDNA accumulation in the liver, but to a lesser extent. Hence, we propose that age-related liver mtDNA segregation is a consequence of macroautophagic clearance of the less-fit mtDNA. Considering that NZB/BINJ and C57BL/6N mtDNAs have a level of divergence comparable to that between human Eurasian and African mtDNAs, these findings have potential implications for humans, including the safe use of mitochondrial replacement therapy. (AU)

FAPESP's process: 19/25049-9 - Mitochondrial formyl peptides as signaling molecules in cardiac Ischemia-reperfusion injury
Grantee:Julio Cesar Batista Ferreira
Support Opportunities: Regular Research Grants
FAPESP's process: 16/07868-4 - Effect of the mitofusins knockout on the inheritance of deleterious mitochondrial DNA in mouse embryonic fibroblasts
Grantee:Carolina Habermann Macabelli
Support Opportunities: Scholarships in Brazil - Doctorate
FAPESP's process: 17/04372-0 - Mitochondrial DNA: mechanisms for genome integrity maintenance and impact on disease
Grantee:Nadja Cristhina de Souza Pinto
Support Opportunities: Research Projects - Thematic Grants
FAPESP's process: 18/20028-0 - Does autophagic deficiency increases accumulation of NZB Mitochondrial DNA in the liver?
Grantee:Katiane Tostes
Support Opportunities: Scholarships in Brazil - Scientific Initiation
FAPESP's process: 17/05899-2 - Effect of the knockout of mitofusins on mouse oocyte: implications to fertility and mitochondrial inheritance
Grantee:Marcos Roberto Chiaratti
Support Opportunities: Regular Research Grants
FAPESP's process: 12/50231-6 - Molecular basis of mitochondrial inheritance: the role of mitochondrial fusion
Grantee:Marcos Roberto Chiaratti
Support Opportunities: Research Grants - Young Investigators Grants
FAPESP's process: 20/15412-6 - Role of mitochondria-endoplasmic reticulum interaction on maternal inheritance of cardiometabolic syndromes
Grantee:Marcos Roberto Chiaratti
Support Opportunities: Regular Research Grants